Soga Shinji, Shirai Hiroki, Kobori Masato, Hirayama Noriaki
Molecular Medicine Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.
J Chem Inf Model. 2007 Mar-Apr;47(2):400-6. doi: 10.1021/ci6002202. Epub 2007 Jan 23.
A novel method for predicting the binding sites for druglike compounds on the surface of proteins was developed on the basis of the specific amino acid composition observed at the ligand-binding sites of ligand-protein complexes determined by X-ray analysis. A profile representing the preference of each of the 20 standard amino acids at the binding sites of druglike molecules was obtained for a small set of high-quality complex structures. An index termed propensity for ligand binding (PLB) was created from these profiles. The PLB index was used to predict the propensity of binding for 804 ligands at all potential binding sites on the proteins whose structures were determined by X-ray analysis. If the sites with the first two highest PLB indices are taken into consideration, the successfully predicted sites reached a high percentage of 86. The PLB prediction is relatively simple, but the validation study showed that it is both fast and accurate to detect ligand-binding sites, especially the binding sites of druglike molecules. Therefore, the PLB index can be used to predict the ligand-binding sites of uncharacterized protein structures and also to identify novel drug-binding sites of known drug targets.
基于X射线分析确定的配体-蛋白质复合物的配体结合位点处观察到的特定氨基酸组成,开发了一种预测类药物化合物在蛋白质表面结合位点的新方法。针对一小部分高质量的复合物结构,获得了一个代表20种标准氨基酸中每一种在类药物分子结合位点处偏好性的图谱。从这些图谱中创建了一个称为配体结合倾向(PLB)的指标。PLB指标用于预测804种配体在通过X射线分析确定结构的蛋白质上所有潜在结合位点的结合倾向。如果考虑PLB指标最高的前两个位点,成功预测的位点比例高达86%。PLB预测相对简单,但验证研究表明,它在检测配体结合位点,尤其是类药物分子的结合位点方面既快速又准确。因此,PLB指标可用于预测未表征蛋白质结构的配体结合位点,也可用于识别已知药物靶点的新型药物结合位点。